5.21
-0.26(-4.75%)
Currency In USD
| Previous Close | 5.47 |
| Open | 5.5 |
| Day High | 5.99 |
| Day Low | 5.17 |
| 52-Week High | 18.55 |
| 52-Week Low | 4.3 |
| Volume | 409,029 |
| Average Volume | 227,052 |
| Market Cap | 136.55M |
| PE | -2.62 |
| EPS | -1.99 |
| Moving Average 50 Days | 8.43 |
| Moving Average 200 Days | 7.79 |
| Change | -0.26 |
If you invested $1000 in CVRx, Inc. (CVRX) since IPO date, it would be worth $186.07 as of January 20, 2026 at a share price of $5.21. Whereas If you bought $1000 worth of CVRx, Inc. (CVRX) shares 3 years ago, it would be worth $348.96 as of January 20, 2026 at a share price of $5.21.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance
GlobeNewswire Inc.
Jan 12, 2026 1:00 PM GMT
Fourth quarter revenue expected to be $15.9 million to $16.1 million, representing growth of 4% to 5%Full year revenue expected to be $56.5 million to $56.7 million, representing growth of 10% to 11%Fiscal 2026 revenue expected to be between $63 mill
CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy
GlobeNewswire Inc.
Jan 06, 2026 1:30 PM GMT
MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascu
CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 22, 2025 1:30 PM GMT
MINNEAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascu